Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nausea
Biotech
Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3
With the trial linking tradipitant to reduced nausea and vomiting in Wegovy patients, the biotech is gearing up for a phase 3 trial in the setting.
Nick Paul Taylor
Nov 18, 2025 10:44am
NASA, Defender to test motion sickness gel for astronauts
Nov 1, 2023 9:00am
What tells our gut to vomit? Scientists have new clues
Nov 2, 2022 3:35am
Acacia gets 2nd FDA rejection as manufacturing fault drags on
May 3, 2019 8:28am
Third time’s the charm: Heron nabs approval for antinausea drug
Aug 10, 2016 10:13am